Back to discover
Drug
Ruthenium
Research stageEmerging research
RxNorm1534768UNII7UI0TKC3U5
1
Research papers
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this drug.
Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives.
Research2020-12-03Drug design, development and therapy
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Canonical name
Ruthenium
RxNorm CUI
1534768
UNII
7UI0TKC3U5
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Journals, researchers & institutions
Top journals
- Drug design, development and therapy1
Leading researchers
- Kim CY1
- Lee SY1
- Nam TG1
Leading institutions
free-text, unnormalised
- Department of Pharmacy and Institute of Pharmaceutical Science and Technology1
References & data sources
- RxNorm (U.S. National Library of Medicine) — drug identity
- Europe PMC — research literature